3QBD
Bacterial Diagnostic Test
Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Company Overview
Snapshot
Founded in January 2000, 3QBD operated with 1–10 employees. The company developed a patented VG-Test device for bacterial diagnosis. 3QBD ceased operations in December 2020.
Business overview
3QBD developed the VG-Test device, a patented diagnostic tool utilizing ion mobility spectrometry technology. This device is designed to rapidly detect bacterial vaginosis, candidiasis, or trichomoniasis within 60 seconds from a vaginal fluid swab, providing immediate and accurate results for effective treatment. The company operated within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices, serving healthcare providers in the gynecology and women's health markets.
Company Intelligence Q&A
- What is 3QBD's primary product?
- 3QBD developed the VG-Test device, a patented diagnostic tool based on ion mobility spectrometry technology designed to detect bacterial vaginosis, candidiasis, or trichomoniasis.
- When was 3QBD founded?
- 3QBD was founded in January 2000.
- What is the operational status of 3QBD?
- 3QBD is non-active and ceased to operate in December 2020.
- What medical conditions can the VG-Test device diagnose?
- The VG-Test device can detect and identify infections of vaginosis, candidiasis, or trichomoniasis.
- What technology does the VG-Test device utilize?
- The VG-Test device is based on ion mobility spectrometry technology.